Screening for Amyloidosis Before Aortic Valve Elective Replacement

Recruiting

• Conditions: I35.0; E85.9; Amyloidosis, unspecified; Aortic (valve) stenosis

• Registration Number: DRKS00025236
• Lead Sponsor: Charité - Universitätsmedizin Berlin

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-05-10
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Recruiting
• Sex: All
• Target Recruitment: 1000

Inclusion Criteria

age =40 years
- written informed consent from the patient or of his/her legal guardian
- hospitalization for AVR due to degenerative aortic valve stenosis

Exclusion Criteria

- hemodynamically unstable patient
- severe co-morbidities with an estimated life expectancy of <1 year

Study & Design

• Study Type: observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
umber/ proportion of ATTR cases identified by systematic screening

Secondary Outcome Measures

Name	Time	Method
Characteristics to differentiate patients with and without ATTR